Open Platform Gene Sampling Chips suit SmartChip System.July 20, 2012 -
MyDesign enables users to dispense assays in variety of configurations to minimize experiment design time. System also makes possible accurate high-throughput qPCR gene expression and single nucleotide polymorphism (SNP) genotyping projects. It is intended for use with SmartChip Real-Time PCR System that allows profiling and validating of molecular biomarkers, microRNA and mRNA gene expression profiling, and SNP genotyping.
Original Press release
WaferGen Biosystems, Inc.
Bayside Technology Center
Fremont, CA, 94538
USA
WaferGen Bio-systems Launches MyDesign - Setting a New Standard in Flexibility with an Open Format High-Throughput qPCR Platform
SmartChip System Supported With a Large Library of Validated Gene Expression Assays
FREMONT, Calif. - WaferGen Bio-systems, Inc. (OTCBB: WGBS) announced today the commercial launch of MyDesign - an open format product offering for its SmartChip System. The key feature of MyDesign is that it allows customers to dispense their own assays in a variety of configurations, thus enabling an easy and rapid design of new experiments. After loading their custom content on MyDesign SmartChips, customers will be able to perform accurate high-throughput qPCR gene expression and single nucleotide polymorphism (SNP) genotyping projects in a simpler and more cost-effective way. Relative to competitive offerings, it is believed that the new SmartChip System has best-in-class flexibility, high levels of sensitivity and dynamic range without the need for preamplification, and a very low cost per reaction. Management believes that these features will position the Company to become a leading provider of high-throughput qPCR solutions.
"The MyDesign concept has greatly expanded our ability to utilize the SmartChip System in our laboratory. We were able to successfully conduct diverse experiments such as long non-coding RNA (lncRNA) expression analysis, as well as perform genotyping and target enrichment for next-generation sequencing. The ability to dispense assays on the spot and to test different configurations has significantly increased the speed of content selection and validation. We are looking forward to deploying the platform in a number of future studies requiring high-throughput qPCR solutions," stated Dr. Jo Vandesompele, Professor of Functional Genomics and Applied Bioinformatics at Ghent University.
In conjunction with the MyDesign launch, WaferGen established a relationship with Integrated DNA Technologies (IDT) to provide PrimeTime qPCR Primers for SYBR-based gene expression assays. Over 800,000 such assays were developed by IDT using a sophisticated design engine that eliminates cross reactivity and includes up-to-date SNP and intron/exon junction information. The two companies will also collaboratively provide custom assay design services for FFPE-derived samples to WaferGen customers.
About WaferGen and the SmartChip Real-Time PCR System
WaferGen Bio-systems, Inc. is an innovative life science company that offers the SmartChip Real-Time PCR System--a next-generation genetic analysis platform for profiling and validating molecular biomarkers. It provides a range of high-throughput capabilities including microRNA and mRNA gene expression profiling as well as single nucleotide polymorphism (SNP) genotyping.
For additional information, please see: http://www.wafergen.com
WaferGen Contact:
John Harland
john.harland@wafergen.com
510-780-2395
SOURCE
WaferGen Bio-systems, Inc.
Web Site: http://www.wafergen.com
|
|
|
|
|
|
|
|
